S&P 500   2,978.76 (-4.42%)
DOW   25,766.64 (-4.42%)
QQQ   205.64 (-5.01%)
AAPL   273.52 (-6.54%)
FB   189.75 (-3.78%)
MSFT   158.18 (-7.05%)
GOOGL   1,314.95 (-5.43%)
AMZN   1,884.30 (-4.81%)
CGC   18.44 (-6.96%)
NVDA   252.60 (-5.62%)
BABA   205.03 (-1.78%)
MU   50.58 (-3.42%)
GE   10.39 (-5.11%)
TSLA   679.00 (-12.81%)
AMD   44.01 (-7.33%)
T   35.73 (-3.69%)
ACB   1.45 (-3.97%)
F   6.97 (-3.33%)
NFLX   371.71 (-1.99%)
PRI   114.78 (-4.46%)
BAC   29.13 (-4.90%)
DIS   118.04 (-4.31%)
GILD   72.66 (-2.73%)
S&P 500   2,978.76 (-4.42%)
DOW   25,766.64 (-4.42%)
QQQ   205.64 (-5.01%)
AAPL   273.52 (-6.54%)
FB   189.75 (-3.78%)
MSFT   158.18 (-7.05%)
GOOGL   1,314.95 (-5.43%)
AMZN   1,884.30 (-4.81%)
CGC   18.44 (-6.96%)
NVDA   252.60 (-5.62%)
BABA   205.03 (-1.78%)
MU   50.58 (-3.42%)
GE   10.39 (-5.11%)
TSLA   679.00 (-12.81%)
AMD   44.01 (-7.33%)
T   35.73 (-3.69%)
ACB   1.45 (-3.97%)
F   6.97 (-3.33%)
NFLX   371.71 (-1.99%)
PRI   114.78 (-4.46%)
BAC   29.13 (-4.90%)
DIS   118.04 (-4.31%)
GILD   72.66 (-2.73%)
S&P 500   2,978.76 (-4.42%)
DOW   25,766.64 (-4.42%)
QQQ   205.64 (-5.01%)
AAPL   273.52 (-6.54%)
FB   189.75 (-3.78%)
MSFT   158.18 (-7.05%)
GOOGL   1,314.95 (-5.43%)
AMZN   1,884.30 (-4.81%)
CGC   18.44 (-6.96%)
NVDA   252.60 (-5.62%)
BABA   205.03 (-1.78%)
MU   50.58 (-3.42%)
GE   10.39 (-5.11%)
TSLA   679.00 (-12.81%)
AMD   44.01 (-7.33%)
T   35.73 (-3.69%)
ACB   1.45 (-3.97%)
F   6.97 (-3.33%)
NFLX   371.71 (-1.99%)
PRI   114.78 (-4.46%)
BAC   29.13 (-4.90%)
DIS   118.04 (-4.31%)
GILD   72.66 (-2.73%)
S&P 500   2,978.76 (-4.42%)
DOW   25,766.64 (-4.42%)
QQQ   205.64 (-5.01%)
AAPL   273.52 (-6.54%)
FB   189.75 (-3.78%)
MSFT   158.18 (-7.05%)
GOOGL   1,314.95 (-5.43%)
AMZN   1,884.30 (-4.81%)
CGC   18.44 (-6.96%)
NVDA   252.60 (-5.62%)
BABA   205.03 (-1.78%)
MU   50.58 (-3.42%)
GE   10.39 (-5.11%)
TSLA   679.00 (-12.81%)
AMD   44.01 (-7.33%)
T   35.73 (-3.69%)
ACB   1.45 (-3.97%)
F   6.97 (-3.33%)
NFLX   371.71 (-1.99%)
PRI   114.78 (-4.46%)
BAC   29.13 (-4.90%)
DIS   118.04 (-4.31%)
GILD   72.66 (-2.73%)
Log in

NASDAQ:CRON - Cronos Group Stock Price, Forecast & News

$6.03
-0.06 (-0.99 %)
(As of 02/27/2020 04:00 PM ET)
Today's Range
$5.41
Now: $6.03
$6.27
50-Day Range
$6.03
MA: $7.34
$8.55
52-Week Range
$5.41
Now: $6.03
$24.37
Volume10.03 million shs
Average Volume10.09 million shs
Market Capitalization$2.10 billion
P/E Ratio6.93
Dividend YieldN/A
Beta3.22
Cronos Group Inc, formerly known as PharmaCan Capital Corp., is a principal investment firm. The firm seeks to invest in companies either licensed, or actively seeking a license, to produce medical marijuana pursuant to Canada's Marihuana for Medical Purposes Regulations “MMPR”. The firm typically invests in companies based in Canada. The firm is primarily an equity investor, may also advance debt as appropriate. Read More…

Industry, Sector and Symbol

Industry Medicinals & botanicals
Sub-IndustryN/A
SectorFinance
Current SymbolNASDAQ:CRON
CUSIPN/A
CIKN/A
Phone212-590-9070

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$12.12 million
Book Value$0.91 per share

Profitability

Net Income$-14,640,000.00
Net Margins4,086.41%

Miscellaneous

Employees291
Market Cap$2.10 billion
Next Earnings Date2/27/2020 (Confirmed)
OptionableOptionable

Receive CRON News and Ratings via Email

Sign-up to receive the latest news and ratings for CRON and its competitors with MarketBeat's FREE daily newsletter.


Cronos Group (NASDAQ:CRON) Frequently Asked Questions

What is Cronos Group's stock symbol?

Cronos Group trades on the NASDAQ under the ticker symbol "CRON."

When is Cronos Group's next earnings date?

Cronos Group is scheduled to release their next quarterly earnings announcement on Thursday, February 27th 2020. View Earnings Estimates for Cronos Group.

What price target have analysts set for CRON?

12 analysts have issued 12-month price objectives for Cronos Group's stock. Their forecasts range from $12.00 to $26.00. On average, they expect Cronos Group's stock price to reach $17.49 in the next twelve months. This suggests a possible upside of 190.1% from the stock's current price. View Analyst Price Targets for Cronos Group.

What is the consensus analysts' recommendation for Cronos Group?

12 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Cronos Group in the last year. There are currently 7 hold ratings and 5 buy ratings for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for Cronos Group.

Has Cronos Group been receiving favorable news coverage?

Media stories about CRON stock have been trending somewhat negative on Thursday, according to InfoTrie Sentiment. InfoTrie rates the sentiment of press coverage by reviewing more than six thousand blog and news sources. The firm ranks coverage of companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. Cronos Group earned a media sentiment score of -1.7 on InfoTrie's scale. They also assigned headlines about the company a news buzz of 0.0 out of 10, indicating that recent press coverage is extremely unlikely to have an effect on the company's share price in the near future. View News Stories for Cronos Group.

Who are some of Cronos Group's key competitors?

What other stocks do shareholders of Cronos Group own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Cronos Group investors own include Canopy Growth (CGC), Aurora Cannabis (ACB), Tilray (TLRY), Aphria (APHA), Dollar Tree (DLTR), NVIDIA (NVDA), Advanced Micro Devices (AMD), Micron Technology (MU), Alibaba Group (BABA) and KushCo (KSHB).

Who are Cronos Group's key executives?

Cronos Group's management team includes the folowing people:
  • Mr. Michael Gorenstein, Chairman, Pres & CEO (Age 31)
  • Mr. David Hsu, Chief Operating Officer
  • Ms. Xiuming Shum, Gen. Counsel & Corp. Sec.
  • Mr. Jeffrey Jacobson, Head of Sales & Bus. Devel.
  • Mr. William Hilson, Chief Commercial Officer

Who are Cronos Group's major shareholders?

Cronos Group's stock is owned by a number of of retail and institutional investors. Top institutional shareholders include Chescapmanager LLC (2.54%), Sumitomo Mitsui Trust Holdings Inc. (0.19%), Swiss National Bank (0.19%), Bank of America Corp DE (0.17%), UBS Asset Management Americas Inc. (0.16%) and Berylson Capital Partners LLC (0.16%).

Which institutional investors are selling Cronos Group stock?

CRON stock was sold by a variety of institutional investors in the last quarter, including Alberta Investment Management Corp, Swiss National Bank, Exane Derivatives, UBS Asset Management Americas Inc., Janus Henderson Group PLC, Public Sector Pension Investment Board, TD Asset Management Inc. and Creative Planning.

Which institutional investors are buying Cronos Group stock?

CRON stock was purchased by a variety of institutional investors in the last quarter, including Connor Clark & Lunn Investment Management Ltd., Chescapmanager LLC, Berylson Capital Partners LLC, Virtu Financial LLC, Wedbush Securities Inc., Oxford Asset Management LLP, BRITISH COLUMBIA INVESTMENT MANAGEMENT Corp and Bank of America Corp DE.

How do I buy shares of Cronos Group?

Shares of CRON can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

What is Cronos Group's stock price today?

One share of CRON stock can currently be purchased for approximately $6.03.

How big of a company is Cronos Group?

Cronos Group has a market capitalization of $2.10 billion and generates $12.12 million in revenue each year. The company earns $-14,640,000.00 in net income (profit) each year or ($0.08) on an earnings per share basis. Cronos Group employs 291 workers across the globe.View Additional Information About Cronos Group.

What is Cronos Group's official website?

The official website for Cronos Group is http://www.thecronosgroup.com/.

How can I contact Cronos Group?

Cronos Group's mailing address is 720 KING STREET W SUITE 320, TORONTO A6, M5V 2T3. The company can be reached via phone at 212-590-9070.


MarketBeat Community Rating for Cronos Group (NASDAQ CRON)

Community Ranking:  2.3 out of 5 (star star)
Outperform Votes:  409 (Vote Outperform)
Underperform Votes:  478 (Vote Underperform)
Total Votes:  887
MarketBeat's community ratings are surveys of what our community members think about Cronos Group and other stocks. Vote "Outperform" if you believe CRON will outperform the S&P 500 over the long term. Vote "Underperform" if you believe CRON will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 2/27/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel